Veeva Systems (NYSE:VEEV) Stock Price Target Raised at Jefferies Financial Group

Veeva Systems (NYSE:VEEV) had its target price lifted by Jefferies Financial Group from $295.00 to $375.00 in a report released on Friday, Benzinga reports. The firm presently has a “buy” rating on the technology company’s stock. Jefferies Financial Group‘s price objective would suggest a potential upside of 23.26% from the company’s current price.

Several other analysts also recently weighed in on the stock. Evercore lifted their target price on shares of Veeva Systems from $185.00 to $250.00 in a report on Thursday, October 8th. Canaccord Genuity Group boosted their price target on shares of Veeva Systems from $220.00 to $260.00 and gave the stock a “hold” rating in a research note on Thursday, August 27th. UBS Group increased their price target on shares of Veeva Systems from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Friday. Barclays raised their price objective on shares of Veeva Systems from $360.00 to $375.00 and gave the company an “overweight” rating in a research report on Wednesday, October 28th. Finally, Stifel Nicolaus set a $300.00 price objective on Veeva Systems in a report on Thursday, August 27th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $309.08.

Veeva Systems Price Performance

Shares of NYSE:VEEV traded down $5.87 during trading on Friday, reaching $304.23. The company had a trading volume of 1,746,403 shares, compared to its average volume of 2,269,820. Veeva Systems has a fifty-two week low of $148.05 and a fifty-two week high of $325.99. The stock’s fifty day moving average price is $289.24 and its 200 day moving average price is $211.95. The firm has a market capitalization of $49.26 billion, a price-to-earnings ratio of 50.04, a price-to-earnings-growth ratio of 1.33 and a beta of 0.89.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The firm had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. During the same period last year, the company earned $1.99 earnings per share. The company’s revenue for the quarter was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, equities analysts anticipate that Veeva Systems will post 6.70 EPS for the current fiscal year.

Insider Activity at Veeva Systems

In other Veeva Systems news, SVP Jonathan Faddis sold 5,198 shares of the company’s stock in a transaction dated Wednesday, October 14th. The shares were sold at an average price of $299.72, for a total transaction of $1,557,944.56. Following the transaction, the senior vice president directly owned 4,130 shares in the company, valued at approximately $1,237,843.60. This represents a 55.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Priscilla Hung sold 750 shares of the stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $261.04, for a total transaction of $195,780.00. Following the completion of the transaction, the director directly owned 3,242 shares of the company’s stock, valued at approximately $846,291.68. This trade represents a 18.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 56,789 shares of company stock worth $14,913,889 in the last ninety days. Corporate insiders own 10.60% of the company’s stock.

Institutional Investors Weigh In On Veeva Systems

Institutional investors and hedge funds have recently modified their holdings of the company. Aberdeen Group plc raised its holdings in Veeva Systems by 1,513.8% during the third quarter. Aberdeen Group plc now owns 2,029,943 shares of the technology company’s stock worth $579,447,000 after purchasing an additional 1,904,153 shares during the last quarter. Fundsmith LLP acquired a new stake in Veeva Systems in the second quarter valued at $144,955,000. Arrowstreet Capital Limited Partnership grew its holdings in Veeva Systems by 203.0% in the first quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company’s stock valued at $160,427,000 after purchasing an additional 611,868 shares during the last quarter. Pacer Advisors Inc. grew its holdings in Veeva Systems by 757.5% in the first quarter. Pacer Advisors Inc. now owns 485,046 shares of the technology company’s stock valued at $85,203,000 after purchasing an additional 428,478 shares during the last quarter. Finally, Ashe Capital Management LP purchased a new position in shares of Veeva Systems in the second quarter valued at $75,232,550. Institutional investors and hedge funds own 88.20% of the company’s stock.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Royal Bank of Canada raised its price target to $365 from $325 and reiterated an “outperform” rating, implying about 20% upside from the cited $304.23 share price. Royal Bank of Canada recommendations
• Positive Sentiment: Needham raised its target to $360 from $310 and maintained a “buy” rating, citing about 18% potential upside from $304.23. Needham recommendations
• Positive Sentiment: Stifel lifted its price target to $340 from $300, adding to the wave of upward target revisions. Stifel raises Veeva price target
• Positive Sentiment: UCB selected Veeva Vault CRM as a core platform for its commercial operations and plans to use industry-specific AI for product launches and customer engagement. The deal supports Veeva’s positioning as a specialized technology provider for life sciences companies. Veeva becomes core CRM choice for major biopharma AI rollout

About Veeva Systems

Veeva Systems Inc is a cloud software company that develops technology for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other healthcare companies that use Veeva’s applications to manage commercial, clinical, regulatory, quality and operational processes.

The company’s Veeva Vault platform provides cloud applications for areas such as clinical data management, electronic trial management, regulatory information, quality management, safety and content management.